What’s ReCELLebrate? Sometimes I end up on mailing lists from companies selling biologics for which I don’t see clear FDA approval. Not all biologics need drug-level approval from the agency, but many do. All exosomes appear to require FDA approval before use. ReCELLebrate is a regenerative firm that just sent me two marketing emails. The […]
ReCELLebrate, IV exosome booth today, & leader Dr. Jeffrey Gross Read More »
Today’s post takes a close look at the exosome manufacturer Kimera Labs in the context of the main exosome companies. What are exosomes? Exosomes are microscopic bubbles or vesicles produced by cells. Exosomes contain many cellular substances that are biologically active. Some of these materials may be helpful clinically, while others could pose risks. Clinical outcomes
Review of where Kimera Labs fits into sphere of exosome companies Read More »
What science and stem cell pubs are you reading right now and what do you hope to get too soon? Sometimes science means getting out in the field. Now there are no wild stem cells out there roaming the fields to catch and analyze, but there are other ways. A couple of my kids and
Weekly reads: Hox, exosome IND app, stem cell quiz, more Read More »
I wrote last week about the Nebraska and Iowa state Attorney Generals filing lawsuits against stem cell clinic firms and three individuals also named as defendants. Although I went into detail about the individuals including leader Travis Autor and the firms, I didn’t yet go into much depth on the state lawsuits themselves in that
Q&A with Roxland on stem cell clinic suits by Iowa & Nebraska Read More »
Some readers suggested earlier this year that I look into a clinic firm called ‘Stem Cell Centers’ with its owner Travis Autor. I didn’t have time to do much since I’ve been very busy in the lab before the state Attorney Generals of Iowa and Nebraska sued them based on a number of allegations including
2 State AG’s sue ‘Stem Cell Centers’ clinics including for alleged fraud Read More »
The FDA dropped a lengthy, extremely critical warning letter on a supplier of unproven exosome product called EUCYT Laboratories. For broader context, exosome therapy has somehow burst onto the scene when there’s no good data yet in my view to back up its use in the clinic. The FDA is taking notice with letters already sent
Getting 30 F grades? FDA Strongly Warns Exosome Firm EUCYT Read More »
My weekly roundups of biomedical news tend to focus on stem cells, but I read more broadly so it’s not just stem cells but also CAR-T cells and a lot more this week. CAR-T cells as senolytics? A team led by Scott Lowe has a new intriguing paper in Nature on using CAR-T cells to
Weekly roundup: CAR-T cells, exosomes, trout cloning Read More »
I’m in the process of gathering data on how much people have been paying for their various stem cell and related treatments, but I’d like to hear directly from you as to what was your stem cell treatment cost. Also, how much did you pay for platelet rich plasma, also known as PRP? What about
Take polls: your stem cell treatment cost, PRP, exosomes Read More »
When the number of stem cell clinical studies and trials listed for COVID-19 first started spiraling upward it seemed likely that stem cell clinics and other firms in that arena would get interested. I thought that we’d see the unproven regenerative medicine coronavirus bandwagon quickly grow. Unfortunately, there are reasons to be increasingly concerned here. For instance,
As clinics buzz about coronavirus, COVID19 patient given non-FDA-approved exosomes? Read More »
The FDA needs to do more about clinics and suppliers of unproven “exosome therapies.” FDA on exosome therapies Dubious exosomes are sadly just the newest gimmick for some firms in the stem cell/regenerative medicine clinic arena right now. They are available at many stem cell and other clinics right now, but who knows what’s in
FDA needs to act boldly on unproven exosome therapies Read More »